Support for Small Business Innovation Research (SBIR) to Development and Testing of New Technologies and Bioengineering Solutions for the Advancement of Cell Replacement Therapies for Type 1 Diabetes (R43/R44 Clinical Trial Not Allowed)

基金名称
Support for Small Business Innovation Research (SBIR) to Development and Testing of New Technologies and Bioengineering Solutions for the Advancement of Cell Replacement Therapies for Type 1 Diabetes (R43/R44 Clinical Trial Not Allowed)
资助机构
HHS-NIH11(National Institutes of Health)
研究领域
Food and Nutrition
Health
截止日期
October 7, 2022 (已过期)
基金规模
$3,000,000
联系方式
National Institutes of Health grantsinfo@nih.gov
申请资格
Small businesses, Other Eligible Applicants include the following: Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, may be allowed.
基金编号
RFA-DK-21-012
说明
This Funding Opportunity Announcement (FOA) invites Small Business Innovation Research (SBIR) grant applications for funding to perform research leading to the development of novel and supportive technologies for the improvement of cell replacement interventions using novel methods, biomaterials and devices for type 1 diabetes (T1D) treatment.

基金资源

NIH General Instructions 下载文件
NIH Application Guide 打开链接
Purdue Grant Writing Lab: Introduction to Grant Writing 打开链接
University of Wisconsin Writing Center: Planning and Writing a Grant Proposal 打开链接

快速分享


将截止日期添加到日历

October 7, 2022

你有想要在此列出的基金申报机会吗?

立即提交你的基金合作意向,发送至 support@peeref.com,我们会尽快为你审核。

相关基金

Doctoral Scholarships
Agriculture June 5, 2023 Upper £1,350,000GBP Lower £90,000GBP Thi...
Smart specialisation, venture capital programme
Agricultural and Biological Sciences December 21, 2023 Up to 1,500,000,000 HUF with total fundi...
Spill Impact Component Project Grants
Natural Resources December 29, 2023 $1,600,500,629
Notice of Intent
Natural Resources May 20, 2024 $200,000